Table 1. Percentage of deliveries where the woman received a prescription for insulin or an antidiabetic medicine in the year before pregnancy, during pregnancy or the year following pregnancy.
Country/region | Entire study cohort | The woman received ≥1 prescription for insulin | The woman received ≥1 prescription for anoral antidiabetic medicine | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Number of deliveries | Mean maternal agea | Year before pregnancy | During pregnancy | Year after pregnancy | Year before pregnancy | During pregnancy | Year after pregnancy | |||||||
N | Years [SDb] | (%) | (95% CI) | (%) | (95% CI) | (%) | (95% CI) | (%) | (95% CI) | (%) | (95% CI) | (%) | (95% CI) | |
Denmarkc | 320,846 | 29.4 [4.8] | 0.37 | (0.35–0.40) | 0.60 | (0.57–0.62) | 0.41 | (0.39–0.43) | 1.22 | (1.18–1.25) | 0.71 | (0.68–0.74) | 0.43 | (0.41–0.46) |
Norwayd | 301,833 | 30.0 [4.9] | 0.45 | (0.43–0.47) | 0.88 | (0.85–0.91) | 0.53 | (0.50–0.55) | 0.75 | (0.71–0.87) | 0.39 | (0.36–0.41) | 0.30 | (0.28–0.32) |
Italy-Emilia Romagnae | 46,445 | 29.7 [5.1] | 0.31 | (0.25–0.36) | 1.03 | (0.93–1.12) | 0.39 | (0.33–0.45) | 0.51 | (0.45–0.58) | 0.30 | (0.25–0.35) | 0.39 | (0.33–0.45) |
Tuscany | 157,916 | 32.3 [5.0] | 0.27 | (0.25–0.30) | 2.22 | (2.15–2.29) | 0.31 | (0.29–0.34) | 0.63 | (0.59–0.66) | 0.40 | (0.37–0.43) | 0.36 | (0.33–0.39) |
The Netherlands | 14,607 | 31.8 [4.9] | 0.38 | (0.28–0.48) | 1.10 | (0.93–1.27) | 0.41 | (0.31–0.51) | 0.29 | (0.21–0.38) | 0.14 | (0.08–0.20) | 0.14 | (0.08–0.20) |
United Kingdomf | 182,920 | 30.1 [6.0] | 0.44 | (0.41–0.47) | 1.01 | (0.96–1.05) | 0.45 | (0.42–0.48) | 0.75 | (0.72–0.79) | 0.61 | (0.57–0.64) | 0.36 | (0.33–0.39) |
Wales | 58,106 | 27.6 [6.1] | 0.37 | (0.32–0.42) | 0.71 | (0.64–0.78) | 0.43 | (0.37–0.48) | 0.97 | (0.89–1.05) | 0.69 | (0.62–0.76) | 0.44 | (0.39–0.49) |
Total | 1,082,673 |
a at the start of pregnancy
b standard deviation
c 1 Jan 2004–31 Dec 2009
d 1 Jan 2005–31 Dec 2010
e 1 Jan 2008–31 Dec 2010
f excluding Wales